ASTRAZENECA PLC-SPONS ADR (AZN)
US0463531089 - ADR
Interesting AZN Call Options For January 2025
3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors...
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first...
July 2025 Options Now Available For AstraZeneca (AZN)
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
AstraZeneca just released some encouraging data about its weight loss drug candidates.
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
AZN earnings call for the period ending September 30, 2024.
AstraZeneca Stock Dives As China's Criminal Probe Rattles Its Third-Quarter Beat
AstraZeneca Chief Executive Pascal Soriot said the company is taking the allegations "very seriously."
AstraZeneca’s 9M and Q3 2024 results
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024
Nasdaq 100 Movers: AZN, GFS
3 Magnificent Stocks Under $100 to Buy in November
The price could be right for these stocks.
December 13th Options Now Available For AstraZeneca (AZN)
3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
In a frothy market starved for value, these three dividend stocks combine reasonable valuations with the proven ability to disrupt themselves.
AstraZeneca Becomes Oversold (AZN)